you are here: HomeNewsTrendsHealth

RBI’s new central office building closed due to COVID-19 threat

Shortly after Covid-19 was declared as a pandemic, the RBI had shifted about 150 officers to an undisclosed location so that the central bank’s core functions remain unaffected

April 28, 2020 / 11:57 AM IST

The Reserve Bank of India’s (RBI) new central office building (NCOB) has been closed for all staff in view of the COVID-19 related situation in Mumbai, according to RBI officials who spoke on condition of anonymity.

“In view of the COVID-19 related situation in Mumbai, it has been decided that the New Central Office Building (NCOB) will remain closed for all staff till further orders. Only a minimum necessary contingent of security personnel will be allowed,” said an internal communication. An RBI spokesperson confirmed the decision.

“In case someone is required to operate from NCOB during this period due to exigency, s/he may obtain the permission of the Deputy Governor concerned. During this period, all staff attached to NCOB are advised to work from home / remote location, in terms of the existing guidelines,” the communication said.

Follow live updates about Coronavirus pandemic in our LIVE blog here

According to one RBI official, one RBI employee and his father-in-law found COVID-19 positive in RBI’s Byculla colony. The colony has been sealed too, the officer said. Moneycontrol couldn't independently confirm this.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Shortly after COVID-19 was declared as a pandemic, the RBI had shifted about 150 officers to an undisclosed location so that the central bank’s core functions remain unaffected.

These officers will continue to operate the critical functions of the central bank in quarantine till the COVID-19 threat is over.

In view of the COVID-19 threat, Prime Minister, Narendra Modi announced a 21-days lock-down beginning 25 March. The lockdown was extended till 3 May in view of the severity of the situation.

Follow all of our coverage on Coronavirus here
Moneycontrol News
first published: Apr 28, 2020 11:52 am

stay updated

Get Daily News on your Browser
Sections